Abstract Objective The transforming growth factor beta-1 gene (TGFB1) is one of the most promising candidate genes for chronic obstructive pulmonary disease (COPD).
Introduction

Chronic obstructive pulmonary disease (COPD) is a major global health problem that causes approximately one million deaths annually worldwide. COPD is predicted to become the third most common cause of death and the fifth most common cause of disability in the world by 2020 (1). Al-though cigarette smoking is the main environmental risk factor (2), genetic factors also likely influence the development of COPD (3, 4). Many case-control studies have investigated the associations of candidate genes with COPD (5, 6); the transforming growth factor beta 1 (TGF-β1) gene (TGFB1) is one such candidate.
TGF-β1 is a multifunctional cytokine that regulates immune responses, cellular proliferation and differentiation, tissue repair, and extracellular matrix production (7, 8) . Evidence from animal studies strongly suggests that abnormalities in TGF-β1 signaling pathways influence the pathogenesis of COPD. Abrogation of active TGF-β1 ligand regulators, including fibrillin-1, latent TGF-β1 binding protein 4, and β6-integrin, caused reduction in lung alveolarization and subsequent development of emphysema accompanied by altered TGF-β1 activity in mice (9) (10) (11) . In addition, Morris et al (11) showed that increased TGF-β1 in the lung parenchyma in a mouse model could protect against emphysema via inhibition of matrix metalloproteinase . These results suggest that compromised TGF-β1 signaling may be correlated with the development of emphysema.
Studies on the association of the TGFB1 single nucleotide polymorphisms (SNPs) with COPD were carried out in several populations, including Caucasians (12) (13) (14) , Koreans (15) , and Chinese (16) 
Subjects and Methods
Selection of cases
n t r a n s l a t e d r e g i o n b y h a t c h e d b l o c k s . T h e a r r o ws i n d ic a t e t h e p o s i t i o n s o f t h e s i n g l e n u c l e o t i d e p o l y mo r p h i s ms e x a mi n e d i n t h e c u r r e n t s t u d y .
(rs2241712, rs1982072, and rs1800469 in the promoter region; rs1982073 in exon 1; rs2241716 and rs4803455 in intron 2; rs6957 and rs2241718 in the 3´region) (Fig. 1) 
Statistical analysis
Continuous data are expressed as mean ± standard deviation (SD). The differences in the continuous variables between cases and controls were analyzed by the
Results
Characteristics of study subjects
Genetic information of the study subjects
The allelic frequencies of the examined SNPs in TGFB1 are shown in T a b l e 1 . S t u d y S u b j e c t Ch a r a c t e r i s t i c s a n d B a s e l i n T a b l e 3 . Al l e l i c F r e q u e n c i e s o f S NP s i n t h e T GF B 1 i n P a t i e n t s wi t h E mp h y s e ma P h e n o t y p e a n d 
e S p i r o me t r y Da t a *
T a b l e 2 . I n f o r ma t i o n o f t h e S e v e r i t y o f Ai r f l o w L i mi t a t i o n De t e r mi n e d b y GOL D Cl a s s i f i c a t i o n a n d T o t a l L AA S c o r e De t e r mi n e d b y Go d d a r d ' s Me t h o d i n P a t i e n t s wi t h E mp h y s e ma P h e n o t y p e type block in both groups (D´>0.8).
Co n t r o l s
T a b l e 4 . P a i r -wi s e L D o f t h e E i g h t S NP s o f t h e T GF B 1 i n P a t i e n t s wi t h E mp h y s e ma P h e n o t y p e a n d c o nt r o l s mo k e r s * respectively), with higher frequencies of the rs1800469T and the rs1982073C alleles in patients in GOLD Stage III-IV compared to patients in Stage I-II (
Discussion
We observed a significant association of the third most common haplotype of TGFB1 in patients with the emphysema phenotype in the Japanese population, although the individual SNP was not associated with the emphysema phenotype. We found that the post-BD %FEV1 was significantly associated with the minor alleles of rs1800469 and rs1982073 SNPs in TGFB1 in patients with emphysema phenotype. However, the total LAA score and %DLco were not associated with TGFB1 SNPs in these patients. Furthermore, the rs1800469T and rs1982073C alleles were significantly more prevalent in emphysema patients with severe and very severe airflow limitation (GOLD Stages III and IV) compared with patients with mild and moderate airflow limitation (GOLD Stages I and II). To our knowledge, this is the first study reporting the association of the TGFB1 polymorphisms with the emphysema phenotype of COPD in a Japanese population.
Celedón et al (12) demonstrated that three TGFB1 SNPs (rs2241712 and rs1800469 in the promoter region, and rs1982073 in exon 1) were associated with COPD in Caucasian smokers with emphysema. In contrast, van Diemen et al (14) observed that the TGFB1 SNP rs6957 in the 3´region was associated with COPD, but they failed to find an association of the two SNPs (rs1800469 and rs1982073) with COPD in Caucasians of Dutch descent. In studies of Asian populations, Su et al (16) reported that rs1800469 is associated with COPD in Chinese, while Yoon et al (15) 
T a b l e 5 . S i g n i f i c a n t Ha p l o t y p e s S t r u c t u r e d b y t h e E i g h t S NP s o f t h e T GF B 1 i n P a t i e n t s wi t h E mp h y s e ma P h e n o t y p e a n d Co n t r o l s *
T a b l e 6 . T h e Di f f e r e n c e s o f t h e P o s t B D %F E V1 b e t we e n t h e E mp h y s e ma P a t i e n t s wi t h a n d wi t h o u t t h e Mi n o r Al l e l e s o f t h e T wo T GF B 1 S NP s
SNPs with the emphysema phenotype of COPD. We suspect that the diversity of LD patterns of different ethnic populations is a likely the reason to explain such inconsistent results. In Caucasians, Celedón et al (12) reported that rs2241712 and rs1800469 in the promoter region were in strong LD, and that these two SNPs were in moderate LD with rs1982073 in exon 1; furthermore, two SNPs in the 3ŕ egion (rs6957 and rs2241718) were found to be in strong LD, but these two SNPs were not in LD with either the two SNPs in the promoter region or the SNP in exon 1. How-
T a b l e 7 . As s o c i a t i o n s o f t h e S i g n i f i c a n t S NP s o f T GF B 1 wi t h t h e S e v e r i t y o f Ai r f l o w L i mi t a t i o n De t e r mi n e d b y GOL D i n P a t i e n t s wi t h E mp h y s e ma P h e n o t y p e
ever, van Diemen et al (14) (21) , and that the rs1982073 (T-29C) SNP, which substitutes leucine (Leu) for proline (Pro) at codon 10, results in increased levels of circulating TGF-β1 (22) . It has been reported that the circulating concentration of TGF-β1 is higher in individuals with the rs1982073C allele than in those with the rs1982073T allele in a Japanese population (23) . The levels of TGFB1 mRNA and protein were upregulated in the airway and alveolar epithelial cells in COPD patients (24) (25) (26) , and the TGFB1 mRNA levels correlated positively with the smoking history and degree of small airway obstruction (26) . Furthermore, the stimulation and activation of TGF-β1 led to subepithelial and peribronchiolar fibrosis in interleukin-13 overexpressing mice (27) . Indeed, Hogg et al (28) 
